India's Piramal Pharma gains after upbeat Q4 results
** Shares of India's Piramal Pharma PIRM.NS up 6.4%,
cooling off from session-high 10.8% jump
** Drugmaker's consolidated adjusted pre-tax profit for Q4
almost trebled, helped by rise in revenue and cost tightening
** Trading volumes 7x the 30-day avg
** YTD stock had risen 15.2%
(Reporting by Hritam Mukherjee in Bengaluru)
((Hritam.Mukherjee@thomsonreuters.com;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma Receives Permanent Revocation Of Closure Order For Dahej Site
Brief: Piramal Pharma Solutions Announces Partnership With Botanix To Support Drug Substance Development
Brief: Piramal Pharma Announces Successful Closure Of Us FDA Inspection At Digwal Facility
India's Piramal Pharma eyes complex drug demand for earnings boost, chair says
Brief: Piramal Pharma Says Closure Of US FDA Inspection At Manufacturing Facility At Lexington